H.D. Smith names EVP
SPRINGFIELD, Ill. — A pharmaceutical wholesaler has promoted one of its executives.
H. D. Smith said Harvey Tanenbaum — an industry veteran with more than 30 years of experience — now will serve as the company’s EVP, responsible for all efforts connected to metro New York area expansion.
Tanenbaum began his career as a practicing pharmacist and also is a former retail pharmacy owner, the company said. He regularly serves in an advisory capacity to such organizations as the Independent Pharmacy Alliance of America, Keystone Pharmacy Alliance, Garden State Pharmacy Owners Association and the Academy of Independent Pharmacy. Tanenbaum also serves on both the New Jersey and New York board of directors for the American Heart Association.
"Ongoing changes in the healthcare market landscape signal the importance of our continued focus on what matters most for our growth and progress — the pharmacy customers that are the backbone of our business. Their needs must be our priority," said Dale Smith, chairman and CEO at H. D. Smith. "Harvey’s applied experience as a retail pharmacist, coupled with his strong passion for the needs of this sector, enables him to champion efforts to provide exceptional customer service and solutions to pharmacies in this region."
Shopping for blood-glucose meters made easy
LUTHERVILLE, Md. — Comparison shopping across blood-glucose meters couldn’t be easier than at Walgreens.
Pictured here at a store just outside of Baltimore, customers can hold and feel the individual monitors and review individual bullet points as part of this pull-box display. Located just outside the pharmacy waiting area, the display also is ideal for quick and easy pharmacist recommendations.
AZ&Me sees participation increase in 2010
WILMINGTON, Del. — Nearly half a million people participated in AstraZeneca’s prescription savings programs.
The drug maker reported that it provided $947 million in savings last year to the more than 545,000 patients in the United States who participated. Participation in the AZ&Me prescription savings programs has increased steadily over the past three years, up 7% over 2009 and 19% over 2008, AstraZeneca said.
An interactive map of the numbers of patients in AZ&Me programs in each state can be found here.